Engy › Who's who in longevity › Jean-Yves Reginster
At a glance
- Physician and emeritus professor of public health and epidemiology at the University of Liège; now also affiliated with King Saud University in Riyadh.
- One of the world’s most prolific researchers on osteoporosis and fractures in older adults, with hundreds of papers on diagnosis, risk assessment and treatment.
- Co-founder of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), which issues recommendations on osteoporosis, osteoarthritis and sarcopenia.
- Recent work covers fracture-risk assessment with imaging and ultrasound, AI-based osteoporosis screening on ordinary chest X-rays, and bone fragility in older adults with diabetes.
- Mentored a generation of researchers on age-related muscle loss in Liège, including Charlotte Beaudart.
- Relevant because for many older people a hip fracture marks the start of lost independence; his work is about spotting that risk in time.
Criticism and nuance
Has worked extensively with the pharmaceutical industry on drug trials. Strontium ranelate, an osteoporosis drug he helped study, was later restricted and withdrawn from the European market because of cardiovascular risks.
Recent
- Study Single-component imaging and ultrasound-based tools for the assessment of fracture risk
- Study Optimizing deep learning-enhanced opportunistic osteoporosis screening from chest X-rays in Australia: Impact of follow-up and treatment adherence on clinical and economic outcomes
- Study Phenotypic Factors and Celecoxib Efficacy in Knee OA: A Post‑hoc Pooled Analysis of Two Randomized, Double‑Blind, Placebo‑Controlled Trials
- Study Driving the future of geriatric and musculoskeletal medicine-the continuing ascent of ACER
- Study Managing Bone Fragility in Older Adults with Diabetes: Pathophysiology, Assessment, and Therapeutic Considerations